Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
sorry intense implosion ..
These intense explosions have uses by the way in medical research ...
useful
destroy kidney stones through shock waves created due to implosion of cavitation bubbles
not so useful
can destroy boat propellers or pump impellers
If Carlsberg farmed shrimps .. it would be a Pincer Shrimp ... no magnets needed ....... "15 million degrees Centigrade"
Reminds me of the importance of neodymium magnets.
https://www.sciencedaily.com/releases/2018/09/180926082731.htm
fascinating .........
https://www.forbes.com/sites/startswithabang/2017/09/05/the-suns-energy-doesnt-come-from-fusing-hydrogen-into-helium-mostly/
How to make the UK one of the richest countries on the planet ...
https://www.telegraph.co.uk/technology/2020/02/16/uk-may-hold-secret-providing-world-limitless-energy/
Pincer shrimps click their unusually large claws so rapidly underwater that their bubbles create shockwaves as loud as a Falcon space rocket launch. At the same time, vapours inside the bubbles reach temperatures in excess of 15mC, causing plasma to form.
Seems to me the lay out of Vulpes in real terms was a lot higher than one could get from L & G.
Well that s see what this week brings us, a fourth collaboration stills close to me. and would like to see a few six figure buys again. Considering the low volumes I think we have been a bit volatile of late, lets see what is to come?
I believe they are still shareholders Knowlesi, mind you the difference betweens both sels of research is about four/five years.
Hi Knowlesi, well buying into the IP and existing managent after completing a high degeree of due diligence is really as much as he could have done to prove to us he is here for the long term.
Do you really think his business know how will be used so sparingly? I don"t but as you say he has more insight than both of us so I will trust his judgement and further to buying in he has of course added to his holding with the 2.950m shares he bought.
I think the only thing we differ on there isI have great hopes for Vulpes involvement and what they can bring to the table. I do think he originally set down his budgets for the research and collaboration timelines, which in effect they have paid for, and knowing how much more will be needed when those funds expire, which will not be so far away, he will one of the first at any table whether it b BioNTech, Avidamab or whoever.. He certainly fitted the profile of what many shareholders felt we needED to liven up ""for our incompetent BOD), LOL.
Strategically it has never been so important as to try and ensure the many platforms are converging in an orderly fuction. I don"t think we have to wait too longer to see how there addition is panning out. and would Scancell have sold 17.33% of the company at 5p and 5.2p if they were not offering the something special the BOD are looking for. ATB
What took my eye was this part................
Vulpes now owns 16.67% of Scancell and Martin Diggle from Vulpes was appointed to the Scancell board, which we believe will increase the chance of a successful outcome for them. The Scancell share price has risen following the Vulpes investment and our investment has been valued at 6.8p, the AIM share price at 31 August.""
It"s just that I believe that too, many have spoken for years about our lack of business accumen and ability to negotiate deals, perhaps there was and Martin Diggle offers very that to the BOD at least, funny though a few negative posters still beat that drum, I am very surprised.
GN
Just having a trawl around , and in recent weeks a gentleman has been building up his holdings in the company, the share price has been moving up too.
This is what Oxford has to say about us in there Haly Year Report back in September.......................
""Scancell, the Company’s only quoted investment, continues to make progress. It has received approval to start the UK Phase 2 melanoma combination trial of SCIB1 and has begun screening potential patients in Nottingham. It has also started the first joint programme on its new AvidiMab anti-glycan antibody technology, having partnered with a large unnamed pharma. AvidiMab antibodies target sugars rather than proteins on the cell surface.
Scancell raised £3.9 million through the issue of new shares at 5p per share, a significant discount to previous placings, to Vulpes Life Science Fund in June. The money will support the transition of Modi-1 to the clinic. Vulpes now owns 16.67% of Scancell and Martin Diggle from Vulpes was appointed to the Scancell board, which we believe will increase the chance of a successful outcome for them. The Scancell share price has risen following the Vulpes investment and our investment has been valued at 6.8p, the AIM share price at 31 August.""
Previous reports are noted by them commenting on an ever decreasing SP, and this was very positive comment, I think they have called this well, and are ""hopeful"" of a successful outcome.
Interestingly the Full Year Report is due sometime in March, will be interesting to see how it pans out and whether the Holding RNSs build up, either way they do a very good report on Scancell and up to date at the time.
OXF 3 TECH Share Price: 55.00Bid: 40.00Ask: 70.00Change: 0.00 (0.00%) .........yes a pretty big spread, lol. but......actual spread is 45/60 but rising the last couple of months.
I rather think the next bit of good news will take us up to 10, but that is IMHO........higher lows!!